Ajanta Pharma has reported results for second quarter ended September 30, 2022.
The company has reported a fall of 15.07% in its net profit at Rs 167.18 crore for the quarter under review as compared to Rs 196.85 crore for the same quarter in the previous year. However, total income of the company increased by 4.51% at Rs 915.60 crore for Q2FY23 as compared Rs 876.12 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported fall of 20.08% in its net profit at Rs 156.60 crore for the quarter under review as compared to Rs 195.94 crore for the same quarter in the previous year. However, total income of the company increased by 7.01% at Rs 978.45 crore for Q2FY23 as compared Rs 914.34 crore for the corresponding quarter previous year.
